Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             38 results found
no title author magazine year volume issue page(s) type
1 Allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia: myths, controversies, and unknowns Gupta, Vikas

117 8 p. 2307-2318
article
2 A mechanistic rationale for MEK inhibitor therapy in myeloma based on blockade of MAF oncogene expression Annunziata, Christina M.

117 8 p. 2396-2404
article
3 A randomized comparison of 4 courses of standard-dose multiagent chemotherapy versus 3 courses of high-dose cytarabine alone in postremission therapy for acute myeloid leukemia in adults: the JALSG AML201 Study Miyawaki, Shuichi

117 8 p. 2366-2372
article
4 ATM regulates a DNA damage response posttranscriptional RNA operon in lymphocytes Mazan-Mamczarz, Krystyna

117 8 p. 2441-2450
article
5 c-Abl regulates Mcl-1 gene expression in chronic lymphocytic leukemia cells Allen, John C.

117 8 p. 2414-2422
article
6 CD8α+ plasmacytoid precursor DCs induce antigen-specific regulatory T cells that enhance HSC engraftment in vivo Huang, Yiming

117 8 p. 2494-2505
article
7 CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies Kohrt, Holbrook E.

117 8 p. 2423-2432
article
8 Cocaine and the blood-brain-barrier Kumar, Mahendra

117 8 p. 2303
article
9 Cocaine-mediated induction of platelet-derived growth factor: implication for increased vascular permeability Yao, Honghong

117 8 p. 2538-2547
article
10 Continuing Medical Education (CME) questions: osteonecrosis in ALL
117 8 p. 2556
article
11 Dentin matrix protein 1 induces membrane expression of VE-cadherin on endothelial cells and inhibits VEGF-induced angiogenesis by blocking VEGFR-2 phosphorylation Pirotte, Sophie

117 8 p. 2515-2526
article
12 Dichotomous regulation of GVHD through bidirectional functions of the BTLA-HVEM pathway Sakoda, Yukimi

117 8 p. 2506-2514
article
13 Double-hit B-cell lymphomas Aukema, Sietse M.

117 8 p. 2319-2331
article
14 Drug interactions with the tyrosine kinase inhibitors imatinib, dasatinib, and nilotinib Haouala, Amina

117 8 p. e75-e87
article
15 Editorial Board
117 8 p. i
article
16 Ex vivo maintenance of hematopoietic stem cells by quiescence induction through Fbxw7α overexpression Iriuchishima, Hirono

117 8 p. 2373-2377
article
17 High-throughput mutation profiling of CTCL samples reveals KRAS and NRAS mutations sensitizing tumors toward inhibition of the RAS/RAF/MEK signaling cascade Kießling, Michael K.

117 8 p. 2433-2440
article
18 How I treat: the selection and acquisition of unrelated cord blood grafts Barker, Juliet N.

117 8 p. 2332-2339
article
19 Human NK cells: SET to kill Leong, Jeffrey W.

117 8 p. 2297-2298
article
20 IL-29 and IFNα differ in their ability to modulate IL-12 production by TLR-activated human macrophages and exhibit differential regulation of the IFNγ receptor expression Liu, Bi-Sheng

117 8 p. 2385-2395
article
21 Megakaryocyte-matrix interaction within bone marrow: new roles for fibronectin and factor XIII-A Malara, Alessandro

117 8 p. 2476-2483
article
22 MEK and MAF in myeloma therapy Popovic, Relja

117 8 p. 2300-2302
article
23 MK2 SUMOylation regulates actin filament remodeling and subsequent migration in endothelial cells by inhibiting MK2 kinase and HSP27 phosphorylation Chang, Eugene

117 8 p. 2527-2537
article
24 Neoangiogenesis contributes to the development of hemophilic synovitis Acharya, Suchitra S.

117 8 p. 2484-2493
article
25 Osteonecrosis in childhood ALL Nachman, James B.

117 8 p. 2298-2299
article
26 Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia Kawedia, Jitesh D.

117 8 p. 2340-2347
article
27 Prognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients: further evidence for CEBPA double mutant AML as a distinctive disease entity Taskesen, Erdogan

117 8 p. 2469-2475
article
28 P2Y6 and vascular inflammation Blackburn, Michael R.

117 8 p. 2304-2305
article
29 Randomized study of induction therapy comparing standard-dose idarubicin with high-dose daunorubicin in adult patients with previously untreated acute myeloid leukemia: the JALSG AML201 Study Ohtake, Shigeki

117 8 p. 2358-2365
article
30 Rara haploinsufficiency modestly influences the phenotype of acute promyelocytic leukemia in mice Welch, John S.

117 8 p. 2460-2468
article
31 RUNX1 mutations are frequent in de novo AML with noncomplex karyotype and confer an unfavorable prognosis Schnittger, Susanne

117 8 p. 2348-2357
article
32 Selective induction of endothelial P2Y6 nucleotide receptor promotes vascular inflammation Riegel, Ann-Kathrin

117 8 p. 2548-2555
article
33 Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation Yap, Damian B.

117 8 p. 2451-2459
article
34 The host genetic background of DNA repair mechanisms is an independent predictor of survival in diffuse large B-cell lymphoma Rossi, Davide

117 8 p. 2405-2413
article
35 The PP2A inhibitor SET regulates granzyme B expression in human natural killer cells Trotta, Rossana

117 8 p. 2378-2384
article
36 The sensing of poorly deformable red blood cells by the human spleen can be mimicked in vitro Deplaine, Guillaume

117 8 p. e88-e95
article
37 Too much ara-C? Not enough daunorubicin? Feldman, Eric J.

117 8 p. 2299-2300
article
38 Unraveling hemophilic arthropathy Abshire, Thomas

117 8 p. 2302-2303
article
                             38 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands